EUVIMEDEUVIMED entdecken
Open Access · CC0

Disentangling the relationship between cancer mortality and COVID-19 in the US

Chelsea L Hansen iD, Cécile Viboud iD, Lone Simonsen iD

eLife · 27.08.2024 · 13

DOI: 10.7554/elife.93758 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 27.08.2024. Verfasst von Chelsea L Hansen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, United States. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: Carlsberg Foundation, Danish National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is considered a risk factor for COVID-19 mortality, yet several countries have reported that deaths with a primary code of cancer remained within historic levels during the COVID-19 pandemic. Here, we further elucidate the relationship between cancer mortality and COVID-19 on a population level in the US. We compared pandemic-related mortality patterns from underlying and multiple cause (MC) death data for six types of cancer, diabetes, and Alzheimer’s. Any pandemic-related changes in coding practices should be eliminated by study of MC data. Nationally in 2020, MC cancer mortality rose by only 3% over a pre-pandemic baseline, corresponding to ~13,600 excess deaths. Mortality elevation was measurably higher for less deadly cancers (breast, colorectal, and hematological, 2–7%) than cancers with a poor survival rate (lung and pancreatic, 0–1%). In comparison, there was substantial elevation in MC deaths from diabetes (37%) and Alzheimer’s (19%). To understand these differences, we simulated the expected excess mortality for each condition using COVID-19 attack rates, life expectancy, population size, and mean age of individuals living with each condition. We find that the observed mortality differences are primarily explained by differences in life expectancy, with the risk of death from deadly cancers outcompeting the risk of death from COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsHumansUnited StatesMaleFemaleAgedSARS-CoV-2Risk FactorsMiddle AgedDiabetes MellitusAged, 80 and overAlzheimer DiseaseAdultPandemics

Stichwörter der Autor:innen

COVID-19cancercancer biologyepidemiologyexcess mortalityglobal healthnone

Autor:innen und Institutionen

  • Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, United States.
  • PandemiX Center, Dept of Science & Environment, Roskilde University, Roskilde, Denmark.
  • Brotman Baty Institute, University of Washington, Seattle, United States.

ORCID-Profile: Chelsea L Hansen, Cécile Viboud, Lone Simonsen

Förderung

  • Carlsberg Foundation
  • Danish National Research Foundation

Zitieren

APA

Hansen, C. L., Viboud, C., & Simonsen, L. (2024). Disentangling the relationship between cancer mortality and COVID-19 in the US. eLife, 13. https://doi.org/10.7554/elife.93758

Vancouver

Hansen CL, Viboud C, Simonsen L. Disentangling the relationship between cancer mortality and COVID-19 in the US. eLife. 2024;13. doi:10.7554/elife.93758

BibTeX
@article{Hansen2024,
  author = {Hansen, Chelsea L and Viboud, Cécile and Simonsen, Lone},
  title = {Disentangling the relationship between cancer mortality and COVID-19 in the US},
  journal = {eLife},
  year = {2024},
  volume = {13},
  doi = {10.7554/elife.93758}
}
Kostenlos starten →